HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

IVIG for the treatment of toxic epidermal necrolysis.

Abstract
Intravenous immunoglobulin (IVIG) has been proposed as a treatment for toxic epidermal necrolysis (TEN) and Stevens-Johnson Syndrome (SJS). A number of retrospective and prospective studies have been conducted, with varying levels of evidence for the efficacy of IVIG. Recent publications provide opposing conclusions. A multi-center, comparative, long-term analysis needs to be conducted to determine the role of IVIG in the management of patients with SJS/TEN.
AuthorsN Mittmann, B C Chan, S Knowles, N H Shear
JournalSkin therapy letter (Skin Therapy Lett) Vol. 12 Issue 1 Pg. 7-9 (Feb 2007) ISSN: 1201-5989 [Print] Canada
PMID17361314 (Publication Type: Journal Article, Review)
Chemical References
  • Immunoglobulins, Intravenous
Topics
  • Humans
  • Immunoglobulins, Intravenous (therapeutic use)
  • Stevens-Johnson Syndrome (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: